Deal Library / Pharma BD Deal Intelligence

Valeant Pharmaceuticals International — Pharma Deals

The Pharma Closeout tracks 3 deals, $3.9B in disclosed deal value, 3 with a post-close Outcome Score for Valeant Pharmaceuticals International.

Median Critic Score: 80  ·  Median Outcome Score: 42

Best outcome: Valeant Pharmaceuticals International / Dow Pharmaceutical Sciences, Inc. (66)  ·  Weakest outcome: Valeant Pharmaceuticals International / Biovail Corporation (18)

All 3 deals

• Valeant Pharmaceuticals International / Dow Pharmaceutical Sciences, Inc. — 2009 · $285M · Largely worked — most objectives met.
• Valeant Pharmaceuticals International / Xcel Pharmaceuticals, Inc. — 2005 · $280M · Underwhelmed — fell short of the thesis.
• Valeant Pharmaceuticals International / Biovail Corporation — 2010 · $3.3B · Did not work — the deal failed to deliver.

← Deal Library  ·  Interactive search  ·  How we score deals